NO20012673L - Nytt farmasöytisk preparat og fremgangsmåte for dets fremstilling - Google Patents

Nytt farmasöytisk preparat og fremgangsmåte for dets fremstilling

Info

Publication number
NO20012673L
NO20012673L NO20012673A NO20012673A NO20012673L NO 20012673 L NO20012673 L NO 20012673L NO 20012673 A NO20012673 A NO 20012673A NO 20012673 A NO20012673 A NO 20012673A NO 20012673 L NO20012673 L NO 20012673L
Authority
NO
Norway
Prior art keywords
pharmaceutical composition
preparation
new pharmaceutical
methyl
thiadiazolidine
Prior art date
Application number
NO20012673A
Other languages
English (en)
Other versions
NO20012673D0 (no
NO329909B1 (no
Inventor
Helle Weibel
Thyge Borup Hjorth
Original Assignee
Reddy Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddy Research Foundation filed Critical Reddy Research Foundation
Publication of NO20012673D0 publication Critical patent/NO20012673D0/no
Publication of NO20012673L publication Critical patent/NO20012673L/no
Publication of NO329909B1 publication Critical patent/NO329909B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
NO20012673A 1998-12-01 2001-05-31 Farmasoytisk preparat og fremgangsmate for dets fremstilling NO329909B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199801580 1998-12-01
PCT/DK1999/000663 WO2000032191A1 (en) 1998-12-01 1999-11-29 New pharmaceutical composition and the process for its preparation

Publications (3)

Publication Number Publication Date
NO20012673D0 NO20012673D0 (no) 2001-05-31
NO20012673L true NO20012673L (no) 2001-05-31
NO329909B1 NO329909B1 (no) 2011-01-24

Family

ID=8106261

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012673A NO329909B1 (no) 1998-12-01 2001-05-31 Farmasoytisk preparat og fremgangsmate for dets fremstilling

Country Status (21)

Country Link
US (1) US7439248B1 (no)
EP (1) EP1135127B1 (no)
JP (2) JP5524435B2 (no)
KR (1) KR100690311B1 (no)
CN (1) CN1158075C (no)
AT (1) ATE316376T1 (no)
AU (1) AU776299B2 (no)
BR (1) BR9915835A (no)
CA (1) CA2352430C (no)
CZ (1) CZ300543B6 (no)
DE (1) DE69929635T2 (no)
ES (1) ES2257886T3 (no)
HU (1) HUP0104544A3 (no)
IL (3) IL143299A0 (no)
NO (1) NO329909B1 (no)
PL (1) PL197077B1 (no)
RU (1) RU2233659C2 (no)
TW (1) TWI235657B (no)
UA (1) UA75569C2 (no)
WO (1) WO2000032191A1 (no)
ZA (1) ZA200104261B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5524435B2 (ja) * 1998-12-01 2014-06-18 ドクター レディーズ ラボラトリーズ リミティド 新規医薬組成物及びその調製のための方法
US20010047032A1 (en) * 1999-12-30 2001-11-29 Castillo Gerardo M. Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases
WO2001091751A1 (en) * 2000-05-30 2001-12-06 Novo Nordisk A/S New pharmaceutical composition and the process for its preparation
JP2004506609A (ja) 2000-05-26 2004-03-04 ノボ　ノルディスク　アクティーゼルスカブ 新たなる医薬組成物及びその調製の為の方法
WO2003051355A1 (fr) * 2001-12-19 2003-06-26 Takeda Chemical Industries, Ltd. Compositions solides refermant des composes instables a l'oxygene et procede de stabilisation de ces composes
WO2006002255A2 (en) * 2004-06-23 2006-01-05 Dr. Reddy's Laboratories Ltd. A pharmaceutical formulation of balaglitazone
CL2008000596A1 (es) * 2007-03-01 2008-09-05 Glaxo Group Ltd Forma de dosificacion que comprende 1-(6-[(3-ciclobutil-2,3,4,5-tetrahidro-1h-3-benzazepin-7-il)oxi]-3-piridinil)-2-pirrolidinona, un estabilizador, un excipiente; procedimiento de preparacion; y su uso para tratar enfermedades neurologicas.

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4280997A (en) * 1978-12-08 1981-07-28 Johannes Van Leverink Extrusion process for the preparation of anhydrous stable lactose
DE3433239A1 (de) * 1984-09-11 1986-03-20 Bayer Ag, 5090 Leverkusen Feste arzneizubereitung enthaltend nitrendipin und verfahren zu ihrer herstellung
CA2019324C (en) * 1989-07-10 1996-08-20 Robert L. Jerzewski Fosinopril tablet formulations
IT1238072B (it) * 1990-01-19 1993-07-03 Sclavo Spa Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
DE69211688T2 (de) * 1991-04-04 1997-02-06 Procter & Gamble Kaubare antacida
EP0511767A1 (en) * 1991-04-29 1992-11-04 Merck & Co. Inc. Tablets containing compound DUP753
TW268952B (no) * 1993-02-26 1996-01-21 Takeda Pharm Industry Co Ltd
CN1133005A (zh) * 1993-09-03 1996-10-09 史密丝克莱恩比彻姆公司 稳定的片剂
US5532256A (en) 1994-05-18 1996-07-02 American Home Products Corporation New azolidinediones and thiadiazolidinediones as antihyperglycemic agents
ES2079327B1 (es) * 1994-12-13 1996-08-01 Lilly Sa Formulaciones farmaceuticas de cefaclor.
DK0800384T3 (da) * 1994-12-14 2001-04-17 Enbalt Trading Ltd Pharmaceutiske tabletformuleringer til direkte kompression
US6395303B1 (en) * 1996-06-10 2002-05-28 Edward Mendell Co., Inc. Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
JPH09249561A (ja) * 1996-03-15 1997-09-22 Teikoku Chem Ind Corp Ltd 医薬組成物
HU222109B1 (hu) * 1996-09-10 2003-04-28 EGIS Gyógyszergyár Rt. Captopriltartalmú tabletták és eljárás ezek előállítására
IL142649A (en) * 1996-12-31 2004-12-15 Reddy Research Foundation Azole derivatives
AU7109798A (en) 1997-12-02 1998-10-30 Dr. Reddy's Research Foundation Substituted thiazolidinedione and oxazolidinedione having antidiabetic, hypol ipidemia and antihypertensive properties
EP0945134A1 (de) * 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation
JP5524435B2 (ja) * 1998-12-01 2014-06-18 ドクター レディーズ ラボラトリーズ リミティド 新規医薬組成物及びその調製のための方法
JP2004506609A (ja) * 2000-05-26 2004-03-04 ノボ　ノルディスク　アクティーゼルスカブ 新たなる医薬組成物及びその調製の為の方法
WO2006002255A2 (en) 2004-06-23 2006-01-05 Dr. Reddy's Laboratories Ltd. A pharmaceutical formulation of balaglitazone

Also Published As

Publication number Publication date
AU1376200A (en) 2000-06-19
JP5524435B2 (ja) 2014-06-18
TWI235657B (en) 2005-07-11
IL179865A (en) 2009-12-24
NO20012673D0 (no) 2001-05-31
IL143299A0 (en) 2002-04-21
IL179865A0 (en) 2007-05-15
BR9915835A (pt) 2001-08-21
KR100690311B1 (ko) 2007-03-09
ZA200104261B (en) 2002-05-24
HUP0104544A2 (en) 2002-08-28
AU776299B2 (en) 2004-09-02
JP2012144560A (ja) 2012-08-02
EP1135127B1 (en) 2006-01-25
ATE316376T1 (de) 2006-02-15
UA75569C2 (en) 2006-05-15
CA2352430C (en) 2008-11-18
US7439248B1 (en) 2008-10-21
JP2002531404A (ja) 2002-09-24
IL143299A (en) 2006-12-31
PL348601A1 (en) 2002-06-03
CN1356901A (zh) 2002-07-03
DE69929635D1 (de) 2006-04-13
NO329909B1 (no) 2011-01-24
HUP0104544A3 (en) 2003-12-29
ES2257886T3 (es) 2006-08-01
PL197077B1 (pl) 2008-02-29
RU2233659C2 (ru) 2004-08-10
DE69929635T2 (de) 2006-09-21
CN1158075C (zh) 2004-07-21
CA2352430A1 (en) 2000-06-08
CZ20011832A3 (cs) 2001-10-17
KR20010099827A (ko) 2001-11-09
EP1135127A1 (en) 2001-09-26
WO2000032191A1 (en) 2000-06-08
CZ300543B6 (cs) 2009-06-10

Similar Documents

Publication Publication Date Title
EE200100594A (et) Uudsed ravimikompositsioonid, mis põhinevad antikolinergiliselt toimivatel ühenditel ja ß-mimeetikumidel
IL158168A0 (en) 5-membered, nitrogen-containing heterocyclic compounds and pharmaceutical compositions containing the same
EE05107B1 (et) Türosiinkinaasi pärssiv ühend, seda sisaldav farmatseutiline kompositsioon ning ühendi kasutamine
HUP0400908A3 (en) Pyrazole compounds useful as protein kinase inhibitors, their use and pharmaceutical compositions containing them
HUP0203841A3 (en) 5-membered heteroaromatic compounds and use thereof for preparation of pharmaceutical compositions, and pharmaceutical compositions containing them
EP1405859A4 (en) NITROGENIC HETEROCYCLIC DERIVATIVE, MEDICAL COMPOSITION, MEDICAL USE AND INTERMEDIATE PRODUCTS CONTAINING THEREOF
EE200200486A (et) Farmatseutilised kompositsioonid, mis sisaldavad 3-aminoasetidiini derivaate, uued derivaadid ja nende valmistamismeetodid
WO2000017190A3 (fr) Derives d'amidines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
ZA200206905B (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same.
HUP0303069A3 (en) Imidazole derivatives, pharmaceutical compositions containing them and their use
HUP0400832A3 (en) New amidoalkyl-piperidine and amidoalkyl-piperazine derivatives, and pharmaceutical compositions containing such derivatives as active ingredients
EE04717B1 (et) Indolüülpiperidiinühendid, nende valmistamismeetod, kompositsioon ja nende kasutamine
HUP0402486A3 (en) Nitrogen containing heterocyclic compounds as peroxisome proliferator activated receptor agonists, their use and pharmaceutical compositions cointaining them
EE200200342A (et) Asendatud 8-arüülkinoliinid, nende kasutamine, farmatseutiline kompositsioon ja prekursorühend
IL157890A0 (en) P-thienylbenzyl-amides serving as agonists of angiotensin-(1-7)-receptors, method for the production thereof, their use and pharmaceutical preparations containing the same
NO326689B1 (no) Pyrrolidinderivater, anvendelse derav, farmasøytisk preparat samt fremgangsmåte for fremstilling av forbindelsene
HUP0200608A2 (en) Heterocyclic compounds, intermediates thereof and elastase inhibitors and pharmaceutical compositions containing them
IL179865A0 (en) Pharmaceutical composition comprising 5 - [[4-[3 - methyl- 4- oxo - 3,4 - dihydro - 2 - quinazolinyl]methoxy] phenyl-methyl]thiadiazolidine-2,4- dione in the form of a tablet a powder or a capsule and the process for its preparation
HUP0202520A3 (en) Substituted benzylthiazolidine-2,4-dione derivatives and pharmaceutical compositions containing them
EE04346B1 (et) Asoolid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
HUP0303155A3 (en) 2-thio-substituted imidazole derivatives, the use thereof and pharmaceutical compositions containing them
HUP0300295A3 (en) Substituted benzamide derivatives, pharmaceutical compositions containing them and their use
AU2001292276A1 (en) Nitrogen-containing compounds and ccr3 inhibitors containing the same as the active ingredient
ITTO20010028A0 (it) Metodo per aumentare l'attivita' antitumorale di una sostanza contenente amigdalina, composizione contenente una sostanza con contenuto aume
HUP0202701A3 (en) Substituted benzylthiazolidine-2,4-dione derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees